Adductor Canal Block Versus Liposomal Bupivacaine in TKA

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 22, 2017

Primary Completion Date

November 25, 2018

Study Completion Date

December 18, 2018

Conditions
Total Knee ArthroplastyPost-operative Pain Control
Interventions
PROCEDURE

Liposomal Bupivacaine Peri-articular Injection

A 20mL solution of 266mg of liposomal bupivacaine (Exparel) was mixed with 40mL of normal saline, which was then infiltrated consistently in the posterior capsule, medial and lateral side of the arthrotomy, patella tendon, quadriceps tendon, quadriceps musculature, and subcutaneous soft tissue.

PROCEDURE

Adductor canal block

Anesthesiologist performs preoperative adductor canal block using 15mL of 0.5% Bupivacaine HCl

Trial Locations (1)

97330

Good Samaritan Regional Medical Center, Corvallis

All Listed Sponsors
lead

Good Samaritan Regional Medical Center, Oregon

OTHER

NCT04086186 - Adductor Canal Block Versus Liposomal Bupivacaine in TKA | Biotech Hunter | Biotech Hunter